Neurontin (Page 9 of 9)

Dosage in Elderly

Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and dose should be adjusted based on creatinine clearance values in these patients.

HOW SUPPLIED

Neurontin (gabapentin) capsules, tablets and oral solution are supplied as follows:

100 mg capsules;

White hard gelatin capsules printed with “PD” on one side and “Neurontin/100 mg” on the other; available in:
Bottles of 100: N 0071-0803-24
Unit dose 50′s: N 0071-0803-40

300 mg capsules;

Yellow hard gelatin capsules printed with “PD” on one side and “Neurontin/300 mg” on the other; available in:
Bottles of 100: N 0071-0805-24
Unit dose 50′s: N 0071-0805-40

400 mg capsules;

Orange hard gelatin capsules printed with “PD” on one side and “Neurontin/400 mg” on the other; available in:
Bottles of 100: N 0071-0806-24
Unit dose 50′s: N 0071-0806-40

600 mg tablets;

White elliptical film-coated scored tablets debossed with “NT” and “16″ on one side; available in:
Bottles of 100: N 0071-0513-24

800 mg tablets;

White elliptical film-coated scored tablets debossed with “NT” and”26″ on one side; available in:
Bottles of 100: N 0071-0401-24

250 mg/5 mL oral solution;

Clear colorless to slightly yellow solution; each 5 mL of oral solution contains 250 mg of gabapentin; available in:Bottles containing 470 mL: N0071-2012-23

Storage (Capsules)

Store at 25°C (77°F); excursions permitted to 15°– 30°C (59°– 86°F) [see USP Controlled Room Temperature].

Storage (Tablets)

Store at 25°C (77°F); excursions permitted to 15°– 30°C (59°– 86°F) [see USP Controlled Room Temperature].

Storage (Oral Solution)

Store refrigerated, 2°–8°C (36°–46°F)

Rx only

logo
(click image for full-size original)

LAB-0106-9.0January 2007

Principal Display Panel

Neurontin®

Gabapentin

300 mg

10 Capsules

bag label
(click image for full-size original)
NEURONTIN gabapentin capsule
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:55154-2415(NDC:0071-0805)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
gabapentin (gabapentin) gabapentin 300 mg
Inactive Ingredients
Ingredient Name Strength
LACTOSE
STARCH, CORN
TALC
gelatin
titanium dioxide
FERRIC OXIDE YELLOW
FD&C BLUE NO. 2
TITANIUM DIOXIDE
Product Characteristics
Color YELLOW (YELLOW) Score no score
Shape CAPSULE (CAPSULE) Size 19mm
Flavor Imprint Code PD;Neurontin;300;mg
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:55154-2415-0 10 BLISTER PACK (BLISTER PACK) in 1 BAG contains a BLISTER PACK
1 1 CAPSULE (CAPSULE) in 1 BLISTER PACK This package is contained within the BAG (55154-2415-0)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA020235 12/30/1993
Labeler — Cardinal Health (188557102)
Establishment
Name Address ID/FEI Operations
Cardinal Health 188557102 REPACK

Revised: 05/2011 Cardinal Health

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2020. All Rights Reserved.